What's New

Bug fixes

App Description

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

iPhone Screenshots

(click to enlarge)

AnticoagEvaluator screenshot 1 AnticoagEvaluator screenshot 2 AnticoagEvaluator screenshot 3 AnticoagEvaluator screenshot 4

iPad Screenshots

(click to enlarge)

AnticoagEvaluator screenshot 5 AnticoagEvaluator screenshot 6 AnticoagEvaluator screenshot 7 AnticoagEvaluator screenshot 8 AnticoagEvaluator screenshot 9

App Changes

  • March 07, 2013 Initial release
  • June 05, 2013 New version 1.1
  • July 14, 2014 New version 1.3
  • August 16, 2014 New version 1.3.59
  • December 12, 2014 New version 1.4
  • December 15, 2014 New version 1.4.1
  • December 17, 2015 New version 2.0
  • November 06, 2016 New version 2.2
  • June 15, 2019 New version 3.0
  • September 16, 2023 New version 4.0
  • April 25, 2024 New version 4.1